BioSpace News Archive

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that its new facility in Rockville, MD has been granted Full Accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

Global pharmaceutical company Mylan N.V.'sboard of directors today released the following statement

STAAR Surgical Company announced the pricing of the previously announced underwritten public offering of 1,739,000 shares of its common stock

BioStem Technologies, Inc. has announced that it has implemented an expanded shareholder communications initiative to provide improved clarity into BioStem’s business plans, upcoming research and development, drug approvals and growth strategy.

Lenabasum has reached Phase 3 clinical stage in two orphan autoimmune indications: systemic sclerosis and dermatomyositis, affecting up to 200,000 patients in the USA, EU and Japan

CollPlant’s American Depositary Shares to continue trading on the Nasdaq Capital Market

ORHub, Inc., a HIPAA compliant, physician-driven digital software company focused on improving profitability and the cost effectiveness of hospitals through real-time smart data and analytics, today provided a corporate update.

Decision Resources Group announced Davis Walp has joined as Chief Strategy Officer.

The U.S. Food and Drug Administration today alerted women and their doctors about serious adverse events related to the improper use of tests intended as an aid in detecting if a pregnant woman’s water has broken (also known as a rupture of the membranes containing amniotic fluid).

Management to Host Conference Call Today at 4:30 p.m. ET